Sinn Arndt
Fachbereich Rechtswissenschaften, Lehrstuhl für Deutsches und Europäisches Straf- und Strafprozessrecht, Internationales Strafrecht sowie Strafrechtsvergleichung, Universität Osnabrück, Heger-Tor-Wall 14, 49076, Osnabrück, Deutschland.
Zentrum für Europäische und Internationale Strafrechtsstudien, Universität Osnabrück, Heger-Tor-Wall 14, 49076, Osnabrück, Deutschland.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Nov;60(11):1245-1254. doi: 10.1007/s00103-017-2627-5.
The trading of illicit and falsified pharmaceuticals is a growth market. Factors influencing this illegal market are high profit margins, a low risk of detection, low control density, an obscure legal situation, and lastly, the easy and anonymous ways of selling over the Internet, usually across national borders. This situation was the background for the research project on the impact of European e‑commerce liberalisation on pharmaceutical crime (ALPhA). The goal of the project was to develop concrete recommendations for action regarding the improved prosecution of internet-based pharmaceutical crime and to create a broad body of data for effective law-making by legislators.In this article the initial situation regarding pharmaceutical crime and its risk potential is described and some of the results from the comparative-law investigation of the ALPhA research project are presented along with its final recommendations. The latter are directed at policy-makers and law enforcement agencies in addition to industry and science and demonstrate the type of framework to be designed to increase safety for the public and to minimize risks when purchasing pharmaceuticals.
非法和伪造药品的交易是一个不断增长的市场。影响这个非法市场的因素包括高利润率、低被发现风险、低管控密度、模糊的法律状况,以及最后,通过互联网销售(通常是跨国销售)的简便且匿名的方式。这种情况是关于欧洲电子商务自由化对药品犯罪影响的研究项目(ALPhA)的背景。该项目的目标是就改进对基于互联网的药品犯罪的起诉制定具体行动建议,并为立法者进行有效立法创建大量数据。本文描述了药品犯罪的初始情况及其潜在风险,并介绍了ALPhA研究项目比较法调查的一些结果及其最终建议。后者除了针对行业和科学界外,还针对政策制定者和执法机构,并展示了为提高公众安全性和在购买药品时将风险降至最低而设计的框架类型。